(Senior) Director, Global Clinical Development
Key Responsibilities:
Responsible for concept development and design of clinical trials andcontributes to the integration of clinical strategy into the overallclinical development plan.
Participate in or lead a matrixed clinical development team,responsible for the generation and maintenance of a scientifically soundclinical development plan aligned with regulatory and commercialstrategies and act as the primary clinical strategy representative onthe core project team and on safety/ risk management teams.
Responsible for clinical development aspects of project planning,protocol concept development and clinical trial design, generation ofstudy synopses, and assessment of clinical study results. Provideclinical review for study relevant documents such as protocols, clinicalstudy reports, Investigator Brochures and review study specific planscovering aspects such as data coding conventions and data reconciliationprocedures, statistical analysis plans and informed consent documents,and provide review of final study reports. Responsible for studyspecific medical responsibility plans to document medical monitoringactivities required for a specific study.
Contribute to the writing of clinical efficacy components ofregulatory dossiers through authoring key clinical sections and provideoversight to contributions from other stakeholders. Provide advice onthe clinical aspects of regulatory strategy in support of the filing ofINDs/CTAs and license applications throughout the development lifecycle.Lead/ contribute to the preparation of clinical sections for regulatorymeetings and attend and present at such meetings (e.g. pre-IND or endPhase 2 meetings/ Scientific Advice/ Advisory Boards) where required.
In collaboration with Clinical Operations, CRO and SAB identify keyinvestigators. Develop and maintain relationships with leadinvestigators within assigned therapeutic area. Additionally, activelyparticipate in investigator meetings.
Act as an internal clinical therapeutic expert developing andmaintaining an understanding of key disease states/etiology, treatments,therapeutic trends, competitive agents for the indications anddevelopment projects within the assigned therapeutic area.
Requirements:
Advanced degree (MD, PhD or PharmD) in life science/healthcare expected
>10 years of Clinical development experience with a working knowledgeof pharmaceutical and regulatory development processes is essential.
Strong leadership and communication skills and a demonstrated abilityto develop constructive and effective relationships
Able to build and lead effective, well integrated, collaborative teams
Works successfully in a matrix organization with multiple disciplinesand to build collaborative relationships
Able to think globally and contemplate multiple aspects and impacts ofissues and plan proactively
三叶草生物成立于2007年,是一家处于临床试验阶段的全球生物制药公司,致力于开发新型疫苗和生物疗法,以应对传染性疾病、癌症和自身免疫性疾病。我们自GenHunter授权引进Trimer-Tag?技术平台,一个用于新型疫苗和生物疗法的产品开发平台。我们的研发管线包括六种Trimer-Tag? 亚单位候选疫苗、两种 Trimer-Tag?肿瘤治疗候选产品以及三种 Fc融合蛋白候选产品。应用Trimer-Tag?技术平台,我们已成为新冠疫苗开发企业并研制了“SCB-2019(CpG1018/铝佐剂)”,以应对由SARS-CoV-2(新冠病毒)引起的新冠大流行。基于积极的“SPECTRA”试验数据,三叶草生物有望成为全球范围内通过COVAX机制率先实现重组蛋白新冠疫苗商业化上市的企业之一。
Trimer-Tag?(蛋白质三聚体化)技术平台可以使任意一个目的蛋白三聚体化*,从而可靶向那些天然依赖蛋白质三聚体化功能的疾病生物学靶点,包括数十种包膜RNA 病毒,如冠状病毒、狂犬病毒、呼吸道合胞病毒(RSV)、流感病毒、人类免疫缺陷病毒(HIV)及埃博拉病毒等,以及肿瘤坏死因子(TNF)超家族(TNFSF)的细胞因子。这些肿瘤坏死因子(TNF)超家族(TNFSF)细胞因子具有多种重要生物学功能,并与某些癌症和自身免疫性疾病相关。
Trimer-Tag?是全球一个利用人源三聚体化标签设计及开发共价连接的重组三聚体融合蛋白(三聚体标签蛋白)的技术平台。由Trimer-Tag?开发的三聚体化蛋白对三聚体依赖性疾病靶点具有很强的有效性及良好的安全性。
公司应用Trimer-Tag?(蛋白质三聚体化)技术平台,并凭借自有的生物制药生产能力,搭建研发管线。
扫码下载APP,找工作更方便